Evidence map›Paper›PMID 40083584›Full record

ArticleCell reports. Physical science2024

Shankar Pandey, Mathias Bogetoft Danielsen, Yuan Xiang, Zhilei Zhang, Grinsun Sharma, Byeong Tak Jeon, Shixi Song, Yitong Hao, Gunan Zhang, Niels Johan Christensen and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell reports. Physical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Advances in the treatment of Alzheimer's disease.Frontiers in pharmacology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Shankar PandeyDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA.
Mathias Bogetoft DanielsenDepartment of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.
Yuan XiangDepartment of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA.
Zhilei ZhangDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA.
Grinsun SharmaSchool of Biomedical Sciences, Kent State University, Kent, OH 44242, USA.
Byeong Tak JeonDepartment of Biological Sciences, Kent State University, Kent, OH 44242, USA.
Shixi SongDepartment of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.
Yitong HaoDepartment of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.
Gunan ZhangDepartment of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA.
Niels Johan ChristensenDepartment of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen, Denmark.
Kasper Kildegaard SørensenDepartment of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen, Denmark.
Pernille HarrisDepartment of Chemistry, University of Copenhagen, Universitetsparken 5, 2100 Copenhagen, Denmark.
Pravin PokhrelDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA.
Richard CunninghamATDBio, Magdalen Centre, Oxford Science Park, 1 Robert Robinson Avenue, Oxford OX4 4GA, UK.
Min-Ho KimDepartment of Biological Sciences, Kent State University, Kent, OH 44242, USA.
Yongsheng LengDepartment of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA.
Chenguang LouDepartment of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.
Hanbin MaoDepartment of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA.

Funding

Supplemental Request for Mechanical Modulation of Cell Migrations by DNA NanoassembliesR01CA252827 · NCI · KENT STATE UNIVERSITY · PI Hanbin Mao · 2023 to 2026
$1.4M
NCI NIH HHS R01 CA252827
6 · The paper itself

Abstract

Small molecules that can reduce the neurotoxic beta-amyloid (Aβ) aggregates in the brain provide a potential treatment for Alzheimer disease (AD). Most screening methods for small-molecule hits focus on the overall Aβ aggregations without a specific target, such as the very first association step (i.e., nucleation)

Identifiers

PMID40083584
PMCPMC11905928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.